Your browser doesn't support javascript.
loading
Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
de Geus, Susanna W L; Eskander, Mariam F; Bliss, Lindsay A; Kasumova, Gyulnara G; Ng, Sing Chau; Callery, Mark P; Tseng, Jennifer F.
Afiliação
  • de Geus SW; Surgical Outcomes Analysis & Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Eskander MF; Surgical Outcomes Analysis & Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Bliss LA; Surgical Outcomes Analysis & Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Kasumova GG; Surgical Outcomes Analysis & Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Ng SC; Surgical Outcomes Analysis & Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Callery MP; Surgical Outcomes Analysis & Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Tseng JF; Surgical Outcomes Analysis & Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: jftseng@bidmc.harvard.edu.
Surgery ; 161(3): 592-601, 2017 03.
Article em En | MEDLINE | ID: mdl-28341441

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatectomia / Neoplasias Pancreáticas / Adenocarcinoma / Terapia Neoadjuvante Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatectomia / Neoplasias Pancreáticas / Adenocarcinoma / Terapia Neoadjuvante Idioma: En Ano de publicação: 2017 Tipo de documento: Article